May 19, 2008
Digitek Recalled over Safety Concerns
Actavis has had to recall its cardiac drug Digitek over serious safety concerns. The recall occurred as a result of some tablets being twice as thick and strength. While the scope of the safety concerns and injuries are not well known, a company spokesperson admitted that the double strength tablets pose a toxicity risk in patients with liver failure. The drug is used to slow down fluttering heart beats but too much of the drug can cause nausea, plummeting blood pressure, and death.
This is not the first time Digitek has encountered problems. The FDA cited Actavis in 2006 for not promptly filing safety reports at one of its New Jersey plants. Thus far, there are several reports of injuries and illness associated with the Digitek recall.
Trackback
You can ping this entry by using http://www.saundersblog.com/cgi-bin/mt/mt-tb.cgi/620 .